Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2017-01-20 Audit Report / Informat…
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
Datum:20.01.2017
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Oehmichen Optik AG for the fiscal year 2015. It contains a balance sheet (Bilanz) and notes (Anhang) detailing accounting principles and financial positions. While it is a financial report, it is not a full 10-K (which is specific to US SEC filings) nor an interim report. Given the structure and content, it represents the core financial reporting of the company, which aligns best with the 'Annual Report' (10-K) category in this taxonomy, as it serves as the official yearly financial disclosure. FY 2015
2017-01-20 German
Datum:05.01.2017
Audit Report / Information Classification · 98% confidence The document is a German 'Jahresabschluss' (Annual Financial Statement) for NanoRepro AG for the fiscal year 2015. It contains the balance sheet (Bilanz), notes to the financial statements (Anhang), and details regarding board members and share capital. This constitutes the core components of an annual report. While it is not a full 10-K (which is a specific US SEC filing), it serves the exact same function as an annual report in the German regulatory context. Therefore, it is classified as an Annual Report (10-K). FY 2015
2017-01-05 German
NanoRepro AG: NanoRepro vertieft Kooperation mit der Paul Hartmann AG
Regulatory Filings Classification · 95% confidence The document is a short news release dated November 8, 2016, announcing the deepening of a cooperation agreement between NanoRepro AG and Paul Hartmann AG regarding the distribution of rapid diagnostic tests under the 'Veroval' brand. It discusses strategic business decisions, product portfolio expansion, and sales outlook. This type of announcement, detailing a significant business development or strategic partnership, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA, POS). Since it is a general corporate news item concerning strategy and business development, and it is not a standard regulatory filing like a Director's Dealing or Major Shareholding notification, the most appropriate general category is 'Regulatory Filings' (RNS) as a fallback for miscellaneous corporate news, although 'Strategic Corporate Decision' might be implied, it is not an available code. Given the options, RNS serves as the best fit for a general, non-financial-statement-focused corporate update distributed via DGAP.
2016-11-08 German
NanoRepro AG: Positiver Umsatztrend setzt sich im 3. Quartal fort
Earnings Release Classification · 100% confidence The document is titled 'NanoRepro AG: Positiver Umsatztrend setzt sich im 3. Quartal fort' and explicitly mentions 'Quartals-/Zwischenmitteilung' (Quarterly/Interim Report) in the DGAP tags. It provides key financial highlights for the 3rd Quarter (Q3 2016), including revenue figures and an updated full-year revenue forecast. This content structure—key results for a period shorter than a year, often released before a full report—is characteristic of an Earnings Release (ER) or an Interim Report (IR). Since it provides specific financial figures and a forecast update, it is more comprehensive than a simple press release announcing results, but it is not the full, detailed report (which would likely be classified as IR if it were comprehensive). Given the focus on quarterly results and the short format (3448 chars), it aligns best with an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Q3 2016
2016-10-19 German
DGAP-DD: NanoRepro AG deutsch
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and contains the header 'DGAP-DD: NanoRepro AG deutsch' followed by 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). Section 1 identifies the person (Frank Müller) and Section 2 identifies his status as 'Aufsichtsrat' (Supervisory Board member). Section 4 details the transaction type ('Kauf' - Purchase) of the financial instrument ('Aktie' - Share) with specific prices and volumes. This content directly corresponds to the definition of Director's Dealing reports.
2016-10-06 German
DGAP-DD: NanoRepro AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains structured information detailing transactions ('Geschäfte') made by a person in a management function ('Personen, die Führungsaufgaben wahrnehmen')—specifically, a member of the Supervisory Board ('Aufsichtsrat'). The content includes the name of the insider (Frank Müller), the type of transaction (Kauf/Buy), the financial instrument (Aktie/Share), prices, and volumes, which perfectly matches the definition of a Director's Dealing report.
2016-10-05 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.